• Exclusive and comprehensive focus on pharma companies worldwide
• Coverage of only small-cap and mid-cap pharma companies
• 100 small-cap/mid-cap companies selected from 600 global pharma companies
• Each round of presentations lays a focus on 25 companies
• Companies to present for 40 minutes with Q&A session of 20 minutes

The Edge here:

• Small/MidCap pharmaceutical companies are not represented in major investment conferences
• Opportunity to have the benefits and visibility of an investment conference - all online and virtual
• Participation of multiple executives from different locations worldwide

The 100 Small/Mid-Cap pharma companies are selected based on the following sequential methodology:

Round One - 600 Companies Selected:

• Compilation of market capitalization of 800 listed global pharma companies
• Ranking of these 800 companies in descending order based on market capitalization
• Exclusion of top 100 companies based on such rankings considering them as Big-Cap
• Exclusion of bottom 100 companies based on such rankings considering them as Micro-Cap

• Then, the remaining 600 companies were considered as a starting point for the ‘Small-MidCap’ universe.

Round Two - 300 Companies Selected:

• For the next round, 300 companies were selected based on these 10 key indicators:
• Composite rank (based on total sales, assets, net income, and equity for latest year in US$)
• Sales growth rank
• Assets growth rank
• Profitability rank (net income to total sales)
• Efficiency rank (total sales to total assets)
• Market capitalization to shareholders’ equity growth
• Gain in stock price for last 12 months
• Shareholders’ equity to total assets
• Research & Development expenses to total sales
• Foreign sales to global sales
• Each of the above indicator was ranked individually for each company and average of available rank values was used to compute deciles
• The top 300 companies with high deciles were selected

Round Three - 100 Companies Selected:

• From these 300 companies, deciles were computed using the quarterly financial data.
• Then, 100 companies with high quarterly deciles were selected for inclusion in the online investment conference.

These questions and answers are provided as a check-list of applicable questions participating companies to include in their presentations:

• Which areas is the company currently focusing on?
• How is your company's performance, given the current economic scenario?
• What kind of growth are you envisaging in the coming quarters?
• What’s the reason for your company's improving profits, despite a high cost environment of your industry?
• What about the current problems that have slowed down your company's growth rate?
• Is the company planning to change its organizational structure?
• How do you see the competition in the current scenario?
• When do you expect to increase your share of market for your products?
• What is the paid-up capital available with the company? Would the company be looking for Foreign Direct Investment (FDI) for more capital?
• Are you considering any medium to long term plans to buy-back your company shares?
• How is the company planning to expand overseas operations?
• How do your company plan to promote exports?
• Is your company open for acquisitions or expansion? What acquisition the company is eyeing?
• What is your forecast for the next six months?

• Visibility to small-cap/mid-cap global pharma companies
• FinGlobe to provide the following to presenting companies:
➢ to issue press release with presenting companies' names included
➢ to distribute free press-passes to relevant trade publications
➢ to place link buttons on web sites of companies selected to present for users to sign-up for selected company presentations
➢ to issue post-presentation press release summarizing key takeaways from presentations
• Companies have the opportunity to reach a broader, global audience versus the audience of a regular investor presentation
• Being part of presentations of a larger group of companies presentations — will generate interest from a wider group of potential viewers
• Provides more presentation time than a typical investor conference
• Senior management beyond CEO and CFO can be part of the presentation
• No costs of travel to be incurred
• Can be timed to be in place of the quarterly financial results call
• Companies have the opportunity to participate each quarter (compared to sell-side conferences which are usually once a year) 

• Total 20 companies will be included on ‘first come first served’ basis for presentations from May 31st-June 3rd, 2016.
• Five companies will present daily during this week of May 31st-June 3rd, 2016 (Tuesday to Friday).

• Companies are allotted 40 minutes presentation time
• Reference material can be provided in advance
• A moderator from FinGlobe will contact company one week prior to presentation to test AV requirements
• Presentation schedule will be announced two weeks in advance for subscribers to sign-up to view presentation live
• The moderator will take questions from subscribers throughout the 40 minutes presentation and then ask such questions in a priority order to the presenting company; Q&A sessions will be for up to 20 minutes in length
• Affiliations of those asking questions will not be disclosed
• Following the presentation, the full video will be available to new subscribers for the duration of one year from date of presentation

Presentation Fees: $ 1500

Select Product Global Pharmaceuticals: Presenting Company Fees

Select Price $1500

• US$100 per presenting company will be charged to attendees
• Discounted rate provided to those users who need access to more company presentations
• Presenting companies will have 10 such user passwords available free
• Financial and trade press will be given free access for 3 companies of their choice
• Medical school libraries, regulatory agencies and trade associations, and independent professionals will be provided 25% discount

FinGlobe will be sending information about the conference presentations to prospective attendees such as:

• Sell-side analysts who follow global pharmaceuticals companies
• Buy-side firms who follow global pharmaceuticals stocks 
• Mutual funds who specialize in healthcare stocks 
• Executives at top 100 global pharmaceuticals companies
• Communications agencies worldwide who work with global pharmaceuticals companies 
• External audit firms of global pharmaceuticals companies 

Please send us an email at info@finglobedirect.com, indicating which presentation(s) a given subscriber would like to attend.

We will announce the list of presentations and timings on May 16, 2016 for presentations scheduled during May 31-June 3, 2016.

Select Product one company presentation 5 companies' presentations 10 companies' presentations 20 companies' presentations

Select Price $100 $400 $600 $900

Discount of 25% for attendees from:

• Medical school libraries
• Regulatory agencies
• pharmaceuticals trade associations
• Independent professionals

Select Product one company presentation 5 companies' presentations 10 companies' presentations 20 companies' presentations

Select Price $75 $300 $450 $675